SLC5A2 and diabetic cardiomyopathy: While Lee et al. focused more on the stabilization of cardiac function through modulation of ionic currents, Rosa et al. highlighted the reduction of oxidative stress and an overall improvement in cardiac structural function, making both studies complementary in illustrating the multi-faceted benefits of SGLT2 inhibitors in diabetic cardiomyopathy.